Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
2.910
-0.130 (-4.28%)
At close: May 9, 2025, 4:00 PM
2.910
0.00 (0.00%)
After-hours: May 9, 2025, 4:05 PM EDT
Agenus Employees
Agenus had 316 employees as of December 31, 2024. The number of employees decreased by 73 or -18.77% compared to the previous year.
Employees
316
Change (1Y)
-73
Growth (1Y)
-18.77%
Revenue / Employee
$327,415
Profits / Employee
-$719,706
Market Cap
79.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AGEN News
- 10 days ago - Agenus to Provide Corporate Update and First Quarter 2025 Financial Report - Business Wire
- 11 days ago - Agenus' BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR - Business Wire
- 14 days ago - Agenus' BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025 - Business Wire
- 16 days ago - Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025 - Business Wire
- 6 weeks ago - Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025 - Business Wire
- 7 weeks ago - Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation - Business Wire
- 2 months ago - Agenus Inc. (AGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program - Business Wire